View all newsletters
Receive our newsletter - data, insights and analysis delivered to you
  1. News
March 10, 2022

Wave Neuroscience unveils new personalised Braincare device

Sonal provides a customised Braincare plan tailored to fit an individual’s needs and help improve brain health.

Braincare Company Wave Neuroscience has launched its new at-home general wellness device, Sonal, for personalised neuromodulation.

Free Report
img

Medical Device Industry Landscape In Asia-Pacific

GlobalData's APAC Medical Devices Industry Landscape – 2022 free study breaks down the APAC medical devices market by segment and region and includes insights on local and global competitors, pipeline product developments, clinical trials studies, and significant deals in the industry. The APAC medical device industry witnessed significant developments, launches, implementations, and adoption of new medical device technologies in the past decade, however the high cost of devices, regulatory hurdles, reimbursement pressure, and healthcare budget constraints have challenged market expansion across various territories and segments. APAC is the fastest growing regional market for medical device clinical trials, with China and Japan emerging as major clinical trial hotspots. The growth in medical device clinical trials in the APAC region is attributed to an increase in research partnerships between biopharma companies and clinical research organizations (CROs). This report also provides an in-depth analysis of the medical device market's opportunities and challenges, the influence of COVID-19 on the market, and government activities aimed to develop the APAC medical device market.
by GlobalData
Enter your details here to receive your free Report.

The device uses non-invasive technology to help reshape brainwaves and effectively improve brain health for general wellbeing.

By providing a customised plan tailored to fit an individual’s needs, Sonal helps to improve brain health and mental wellness.

Wave Neuroscience CEO Fred Walke said: “By introducing the first at-home device, we are able to remove one roadblock some face when deciding whether to seek care.”

To create a personalised Braincare plan, an individual’s brainwaves will be recorded for ten minutes and then reviewed by the Department of Data Science at Wave using neurocomputational analytics.

The individualised plan will be uploaded to the mobile Sonal app once created.

Sonal sessions take 30 minutes, and users may experience increased focus, improved sleep quality and elevated mood.

Users may also notice a significant improvement in self-control by using the device for consecutive weeks.

It also improves Heart Rate Variability (HRV), which is connected to resilience to stress and improved deep sleep.

Wave Neuroscience president and chief medical officer Erik Won said: “One of our core values is democratising brain health and the development of Sonal is a tremendous step in the right direction.

“Neuronal function can gradually degrade over time due to numerous factors and stressors, such as chronic stress, sleep disruption, loss of a loved one, traumatic events, substance use and more.

“The Sonal has demonstrated promising data in double-blind randomised clinical trials at elite academic institutions.”

Sonal is a mobile wearable device that can be used for personalised Braincare anywhere.

Related Companies

Free Report
img

Medical Device Industry Landscape In Asia-Pacific

GlobalData's APAC Medical Devices Industry Landscape – 2022 free study breaks down the APAC medical devices market by segment and region and includes insights on local and global competitors, pipeline product developments, clinical trials studies, and significant deals in the industry. The APAC medical device industry witnessed significant developments, launches, implementations, and adoption of new medical device technologies in the past decade, however the high cost of devices, regulatory hurdles, reimbursement pressure, and healthcare budget constraints have challenged market expansion across various territories and segments. APAC is the fastest growing regional market for medical device clinical trials, with China and Japan emerging as major clinical trial hotspots. The growth in medical device clinical trials in the APAC region is attributed to an increase in research partnerships between biopharma companies and clinical research organizations (CROs). This report also provides an in-depth analysis of the medical device market's opportunities and challenges, the influence of COVID-19 on the market, and government activities aimed to develop the APAC medical device market.
by GlobalData
Enter your details here to receive your free Report.

NEWSLETTER Sign up Tick the boxes of the newsletters you would like to receive. The top stories of the day delivered to you every weekday. A weekly roundup of the latest news and analysis, sent every Friday. The medical device industry's most comprehensive news and information delivered every month.
I consent to GlobalData UK Limited collecting my details provided via this form in accordance with the Privacy Policy
SUBSCRIBED

THANK YOU

Thank you for subscribing to Medical Device Network